See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Alex Vellor

Author: Alex Vellor
09:00am, Wednesday, Jul 17, 2024
Johnson & Johnson Exceeds Expectations in Q2, Boosts Full-Year Outlook
Johnson & Johnson (NYSE: JNJ) surpasses Q2 estimates with $2.82 EPS and $22.45B revenue, raising the full-year 2024 outlook. Shares rise 2.1% on strong performance.
Read More
09:53am, Tuesday, Jul 16, 2024
Morgan Stanley Surpasses Q2 Estimates